BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11809185)

  • 1. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study.
    van Dam MJ; de Groot E; Clee SM; Hovingh GK; Roelants R; Brooks-Wilson A; Zwinderman AH; Smit AJ; Smelt AH; Groen AK; Hayden MR; Kastelein JJ
    Lancet; 2002 Jan; 359(9300):37-42. PubMed ID: 11809185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.
    Clee SM; Kastelein JJ; van Dam M; Marcil M; Roomp K; Zwarts KY; Collins JA; Roelants R; Tamasawa N; Stulc T; Suda T; Ceska R; Boucher B; Rondeau C; DeSouich C; Brooks-Wilson A; Molhuizen HO; Frohlich J; Genest J; Hayden MR
    J Clin Invest; 2000 Nov; 106(10):1263-70. PubMed ID: 11086027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited disorders of HDL metabolism and atherosclerosis.
    Hovingh GK; de Groot E; van der Steeg W; Boekholdt SM; Hutten BA; Kuivenhoven JA; Kastelein JJ
    Curr Opin Lipidol; 2005 Apr; 16(2):139-45. PubMed ID: 15767853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.
    Lucero D; Sviridov D; Freeman L; López GI; Fassio E; Remaley AT; Schreier L
    Atherosclerosis; 2015 Sep; 242(1):236-42. PubMed ID: 26232163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between increased carotid intima-media thickening and decreased HDL-cholesterol in a family with a novel ABCA1 variant, G2265T.
    Hong SH; Riley W; Rhyne J; Friel G; Miller M
    Clin Chem; 2002 Nov; 48(11):2066-70. PubMed ID: 12407001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia.
    Bellanger N; Orsoni A; Julia Z; Fournier N; Frisdal E; Duchene E; Bruckert E; Carrie A; Bonnefont-Rousselot D; Pirault J; Saint-Charles F; Chapman MJ; Lesnik P; Le Goff W; Guerin M
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1675-81. PubMed ID: 21527752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis.
    Attie AD; Kastelein JP; Hayden MR
    J Lipid Res; 2001 Nov; 42(11):1717-26. PubMed ID: 11714841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.
    Hovingh GK; Van Wijland MJ; Brownlie A; Bisoendial RJ; Hayden MR; Kastelein JJ; Groen AK
    J Lipid Res; 2003 Jun; 44(6):1251-5. PubMed ID: 12700344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic individuals with high HDL-C levels overexpress ABCA1 and ABCG1 and present miR-33a dysregulation in peripheral blood mononuclear cells.
    Scherrer DZ; Zago VH; Parra ES; Avansini S; Panzoldo NB; Alexandre F; Baracat J; Nakandakare ER; Quintão EC; de Faria EC
    Gene; 2015 Oct; 570(1):50-6. PubMed ID: 26051418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden.
    Bochem AE; van Wijk DF; Holleboom AG; Duivenvoorden R; Motazacker MM; Dallinga-Thie GM; de Groot E; Kastelein JJ; Nederveen AJ; Hovingh GK; Stroes ES
    Eur Heart J; 2013 Jan; 34(4):286-91. PubMed ID: 23136402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
    Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
    Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells.
    Choi HY; Rahmani M; Wong BW; Allahverdian S; McManus BM; Pickering JG; Chan T; Francis GA
    Circulation; 2009 Jun; 119(25):3223-31. PubMed ID: 19528336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
    Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
    Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function.
    Patel DC; Albrecht C; Pavitt D; Paul V; Pourreyron C; Newman SP; Godsland IF; Valabhji J; Johnston DG
    PLoS One; 2011; 6(7):e22142. PubMed ID: 21829447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of ATP-binding cassette transporters in hypertensive patients.
    Xu M; Zhou H; Gu Q; Li C
    Hypertens Res; 2009 Jun; 32(6):455-61. PubMed ID: 19390536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-β1 HDL in type 2 diabetes mellitus.
    Shiu SW; Wong Y; Tan KC
    Atherosclerosis; 2017 Aug; 263():24-28. PubMed ID: 28595104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?
    Pajukanta P
    J Clin Invest; 2004 Nov; 114(9):1244-7. PubMed ID: 15520856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.